JPRN-jRCT1030220416
Recruiting
未知
Validation of neuroprotective factors reflecting exercise effects in patients with Parkinson disease.
Ando Maya0 sites120 target enrollmentOctober 27, 2022
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Ando Maya
- Enrollment
- 120
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Patient (Hoehn and Yahr I,II) with diagnosis of Parkinson disease according to the 2015 MDS (International Parkinson and Movement Disorder Society) crinical diagnostic criteria of Parkinson disease.
- •2\. Able to come to Juntendo University Koshigaya hospital regularly during the study period.
- •3\. Older than 40 years old and yonger than 80 years old with no dementia criteria of a MMSE at a baseline \>\= 26\.
Exclusion Criteria
- •1\.Yonger than 39 years old and older than 81 years old.
- •2\.Patient with diagnosis of cerebrovascular disease, neuroimmunological disease, seizure disorder and neurodegenerative disease, such multiple system atrophy, progressive supranuclear pulsy and Alzheimer disease.
- •3\.Patient with an abnormal ECG or past medical history of coronary infarction. Patient with an obvious orthostatic hypotension.
- •4\.Patient with a hepatic disorder, a renal disorder and malignancy.
- •5\.Others that investigators judged inappropriate.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 2
Neuroprotective Therapy and Therapeutic Target in Emergency DepartmentStrokeDehydrationNCT02143596Chang Gung Memorial Hospital159
Not yet recruiting
Not Applicable
Brain protection in Intracranial Aneurysm surgeryHealth Condition 1: I671- Cerebral aneurysm, nonrupturedCTRI/2022/07/044141Aparna S Nair
Completed
Phase 2
Evaluation of the neuroprotector effect of an extract of stem bark of Mangifera indica L. (Vimang®) in patient with Spinocerebellar Hereditary Ataxia Type 2Spinocerebellar Hereditary Ataxia Type 2Spinocerebellar AtaxiasCerebellar AtaxiaAtaxiaSpinocerebellar DegenerationsCerebellar DiseasesHeredodegenerative Disorders, Nervous SystemNeurodegenerative DiseasesNervous System DiseasesSpinal Cord DiseasesDyskinesiasNeurologic ManifestationsGenetic Diseases, InbornBrain DiseasesRPCEC00000005Center of Pharmaceutical Chemistry20
Completed
Phase 3
A trial of neuroprotective vitamin D in traumatic brain injury patientsIRCT20191026045243N2Sari University of Medical Sciences84
Completed
Not Applicable
A comparative study of neuroprotective strategies in neonatal hypoxic ischaemic encephalopathyNeonatal DiseasesPACTR202006515915908SAMRC40